MK
Michael W Katz
10% Owner

Michael W Katz insider trades: Organogenesis Holdings (ORGO) stock purchases

10% Owner, Organogenesis Holdings Last trade Nov 21, 2022 18 Form 4 filings
$0
Sold, last 12 months
0 sales
$0
Bought, last 12 months
0 buys
13
Open-market trades
since 2012
3
Companies
last trade 2022

Trades on the price chart

Daily close, with an arrow on each day they bought or sold

Companies

Where Michael reports to the SEC

Open-market buys and sales

13 trades reported on SEC Form 4, newest first

DateStockTypeValue
Nov 21, 2022ORGO↑ Buy$15K
May 16, 2022ORGO↑ Buy$60K
Dec 13, 2021ORGO↑ Buy$5K
Dec 3, 2021ORGO↑ Buy$25K
Nov 29, 2021ORGO↑ Buy$10K
Nov 26, 2021ORGO↑ Buy$20K
Nov 17, 2021ORGO↑ Buy$56K
Aug 17, 2021ORGO↑ Buy$163K
Nov 17, 2020ORGO↑ Buy$68K
Sep 13, 2019ORGO↑ Buy$22K
Sep 4, 2019ORGO↑ Buy$45K
Dec 31, 2012PERF↑ Buy$7K
Dec 13, 2012PERF↑ Buy$37K

Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.

Other ORGO insiders

Open-market trades in the last 12 months

About Michael W Katz's insider trades

Michael W Katz is a 10% owner of Organogenesis Holdings (ORGO). Since Dec 13, 2012, Michael has reported 13 open-market purchases worth $531K and no sales on SEC Form 4. There have been no open-market trades in the last 12 months.

Their filings also include grants and awards (4 filings), shares returned to the company (1 filing). These aren't open-market trades and aren't counted above.

How to read insider trades

Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every ORGO insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.